Business Wire

FL-ACR-ELECTRONICS

4.5.2015 14:12:44 CEST | Business Wire | Pressemeddelelse

Del
ACR Electronics Announces Acquisition of Ocean Signal

ACR Electronics, Inc., a Drew Marine company and the global leader in safety and survival technologies, today announced its acquisition of Ocean Signal, Ltd., an innovative supplier of marine safety and survival equipment.

ACR and Ocean Signal have two of the most highly experienced electronic engineering teams in the marine communication industry. Combined they now have the in-house capabilities to develop the next generation of survival products for the maritime, terrestrial, military, and aviation markets.

“Ocean Signal has pioneered a number of innovations in marine safety,” said Gerry Angeli, President of ACR Electronics. “Their ability to create a strong brand in a short period of time is a testament to their product design, quality and understanding of the market. Like ACR, Ocean Signal is known for reliable products that perform in the worst conditions the first time, every time and we are excited to add them to our team.”

The combination of the ACR and Ocean Signal brands bolster the product lines for the marine market place. Together the companies offer a full range of Emergency Position Indicating Radio Beacons, Personal Locator Beacons, Search and Rescue Transponders, AIS Man Overboard Beacons, VHF radios, Searchlights, rescue strobe lights, pyrotechnics, and safety accessories.

Ocean Signal Managing Director Alan Wrigley said: “This is an exciting time for Ocean Signal and ACR. This combination will allow Ocean Signal to expand its capabilities and together we will redefine safety and survival technology in order to save more lives around the world – which is the objective we are all working towards.”

Financial terms of the acquisition will not be released.

About ACR Electronics, Ltd.

ACR Electronics, Inc., a Drew Marine company, is a world leader in safety and survival technology. ACR designs, manufactures, and markets a comprehensive product line of electronic survival products for the maritime, aviation, outdoor AND military markets. ACR product lines include a full range of 406 MHz distress beacons including EPIRBs, Personal Locator Beacons, and ARTEX ELTs, as well as Search and Rescue Transponders (SARTs), Rescue Strobe Lights, Searchlights, VHF Radios and Survival Accessories.

ACR’s headquarters and manufacturing is located in Fort Lauderdale, FL and is registered to the international quality system standards AS9100C (Aerospace) and ISO-9001. Additionally ACR maintains FAA Part 145 Repair Station Certification status. For more information about ACR Electronics, or any of ACR’s brands including ARTEX, please go to  www.ACRARTEX.com .

About Ocean Signal

Communication and safety at sea specialist Ocean Signal™ is dedicated to providing the technology and quality of product that will set industry standards.

Ocean Signal’s rescueME range of products, which includes the rescueME PLB1, the rescueME MOB1, the rescueME EPIRB1 and the rescueME EDF1 electronic distress flare, and SafeSea range of GMDSS products, including the E100 and E100G EPIRB, S100 SART and V100 handheld VHF radio, provides both recreational and commercial mariners with simple to use, compact and affordable life-saving solutions. All products are engineered by a highly experienced team of marine electronics professionals.

Safety and communication products from Ocean Signal offer exceptional value, meeting or exceeding international technical and safety standards. Careful design and innovation provides commercial shipping, fishing and recreational users the confidence that their Ocean Signal equipment will work to, and beyond, their expectations when it is needed most.

For further information on the full range of products available from Ocean Signal, please go to www.oceansignal.com .

All other brands, product names, company names, trademarks and service marks are the properties of their respective owners. All rights reserved.

Contact:

ACR Electronics, Inc.
Media Relations:
Mikele D’Arcangelo, +1 954-862-2115
Mikele.Darcangelo@acrartex.com
www.acrartex.com

Link:

Multimedia Gallery

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release

The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye